Introduction

B���� ��j��� �� ������� ������s �s ������d �� ������������ responses and viral infections (1). Herpes simplex virus (HSV)
��������� �s ��� �� ��� ������ ����s �� ������������ v���� ���������, w��� ~2.5% ����d���� �� ���g���� w���� ��d 0.04% ����d���� �� �������s (2) . M��� s��d��s ��v� s��w� ���� ��� ����k���-��d���d ������������ ��s���s� �s ��� ���� �������s� �� ��������� ���������-��d���d ����� ��j���. P����g��s ��� ���� �� ����� ��� ����s v�� �������� s�s���s, thus increasing the risk of fetal inflammation syndrome, and inflammatory cytokines can enter the fetal brain via the circu-������, �����������g �� �dv��s� �����d�v���������� �������s. A����d��g��, �������v� ��d ������������ �����v������ �� ���g-���� w���� w��� ��������� ������������ v���� ���������s �s �������� ��� ���������g ��� �������� ������������� �� ������� �������s (3) . I� ��� ��s�, ����������� ����� ����������-���� (��EPO) w�s g�������� �s�d ��� �������g ������, �����d��g g�s�������� ������, w��� � ��g� d�g��� �� s����� (4) . H�w�v��, ��� ���-������������� ��������s �� ��EPO ��v� �������� ��������d �������� ���������, ����s��g �s�������� �� ��s �����-��������v� �����������s. I�d��d, ��� ������� �� ��EPO �� ������� �g���s� ����� ��j����s ��s ���� ��v�s��g���d �� �������� ���s (5) . A� ���s s��g� ����g�, ��� ��j����� �� s��d��s ��v� ����s�d �� �������s ��d ������ ��d��s, w��� �� �������� ��v�s��g����� �� ������������ ��EPO �����v������. T�� ���s��� s��d�, ��v��g ��d��s���d ��� �������d s����� �� ��EPO �����v������ �� ���g-���� w����, ��v�s��g���d ��� �������������v� �����������s �� ��EPO �����v������ �s �� �dj�v��� ������� �� ���g���� w���� �������d w��� ������������ �����s v���s.
Patients and methods
Patient information. O�� ���d��d ��d �w���� w���� �������d with perinatal intrauterine herpes virus treated at the Second P�����'s H�s����� �� L�������g ���w��� J���, 2012 ��d
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August, 2014 were selected. The inclusion criteria were defined in accordance with 'Chinese Obstetrics and Gynecology' (6) . Selected patients presented fever (>37.5˚C), heart rate >100 bpm, fetal heart rate >160 bpm, abnormal amniotic fluid smell, uterine tenderness, CRP >8 mg/l, WBC >15x10 9 /�. A�� s������d patients were required to provide voluntary informed written ���s��� ����� �� ���������� �� ��� s��d�. P���������� �x���s��� criteria were as follows: i) allergy to the selected medicine; ��) ��v��g ���g�����-��d���d ��������s���, d������s, �� ���������s��, ����� ���g�����-������d ������������s, �� serious internal diseases; iii) refusal to provide consent.
Fetus inclusion criteria were as follows: i) gestational age <37 weeks, in line with diagnostic criteria for preterm children; ��) ���s���� �� �������� �����g��s �� ����� ������g��� s����-tions, urine, or blood. Fetus exclusion criteria were as follows: i) allergy to the selected medicine; ii) presence of any other ���g������ d�s��s�s. P����������s w��� ���d���� �ss�g��d ���� ���� g����s �� 30 ����: A, B, C ��d D. M������� ��d ����� ��s�-���� d��� ��� ��� ���� g����s ��� s��w� �� T����s I ��d II. N� significant differences in any parameter were found between any of the groups (P>0.05). The study was approved by the Ethics Committee of the Second People's Hospital of Liaocheng.
Intervention methodology. P����������s �� ��� ���� g����s w��� g�v�� ��� s��� ��s����� ������������ ��������� �����-����, w��� ��EPO �d����s������� ���� ����� ����� ���������s w��� ��d�� �������. P����������s �� g���� A w��� ������d w��� 1,500 IU rhEPO doses (S20030068; Shanghai HKB Co., Ltd., Shanghai, China) via slow intravenous injection every 3 d��s ����� d���v���. P����������s �� g���� B ��d��w��� ��� s��� �����d��� �x���� ��� d�s�g� w�s 3,000 IU ��EPO. I� g���� C, �������s w��� �����v����s�� �d����s����d 250 IU/kg ��EPO 3 ����s/w��k ���� 2-3 d��s ��s�-����� ����� 1 �����. P����������s �� g���� D w��� ��� g�v�� ��EPO �� ��� ����. H� ��v��s w��� ���s��� ��������d �����g���� ��� s��d� �����d, with Hb levels >220 g/l resulting in termination of rhEPO �d����s������� �� ���v��� �����-�����������s�s.
Measured parameters. T�� �����w��g ���������s w��� ���s���d ����d������ ����� d���v��� (T 0 ) ��d 1 (T 1 ), 2 (T 2 ), ��d 4 w��ks ����� d���v��� (T 3 ): ����g����� (H�), ��������-cyte (Ret), hematocrit (Hct), neuronspecific enolase (NSE), myelin basic protein (MBP), and S100 calcium-binding protein B (S100B). The linear relationships and the correlation coefficient r between Hb, Ret and Hct with NSE, MBP and S100B were analyzed. Receiver operating characteristic (ROC) ���v� ��d��s w��� �s�����s��d �� d�������� ��� �v�������� v����s �� H�, R�� ��d H�� ��� ����� ��j��� �� ������� ������s ��d ����� ������� ���-��� v����s.
Statistical analysis. SPSS 19.0 (IBM, Armonk, NY, USA) w�s �s�d �� d��� �����s�s. M��s������� d��� w��� �����d�d as (mean ± SD), and the comparison of multiple time-points ���w��� ��� ���� g����s w�s ���������d v�� �������d ���s���s analysis of variance (rANOVA). Multivariate analysis of variance (MANOVA) was used for single time-point comparisons while least significant difference (LSD) was �s�d ��� ����-�������s��s. Odds ����� (%) w�s ���������d and Mann-Whitney U test was used to compare pair-data. Chi-square test was applied in mortality and bacterial eradica-���� �����������s, d��� w��� �����z�d v�� ������ ����������� ��d P<0.05 indicated statistical significance.
Results
Incidence of brain injury. T�� ����d���� �� ����� ��j��� in groups A, B, C and D were 10% (3/30), 6 
Differences in specific brain injury indicators in preterm infants.
As shown in Table IV , NSE, MBP and S100B levels were signifi-������ ��w�� �� g����s A ��d B vs. g����s C ��d D �� T 0 (P<0.05), w���� �� T 1 , T 2 ��d T 3 , there was no significant difference among groups A, B and C (P>0.05), but all three showed significantly lower NSE, MBP and S100B levels than group D (P<0.05).
Correlation between blood indicators and specific brain injury indicators. As shown in Table V (Fig. 1) .
Discussion
I� �s ���������� ����g��z�d ��d�� ���� ������� ������ ����� ��j��� �s ������ ������d �� ����x��/�s������ ��d ������������ ���������s, w��� ��� ��s� ������ ���� �� ����� ��j��� ����g white matter lesions (7). HSV is one of the common types of intrauterine infection, and studies have confirmed that infants can be infected with HSV at birth, manifesting as lesions of the ������� ���v��s s�s��� ��d sk�� (8) . D�������� v���� ���������s have affinity for different organs, thus leading to significant individual differences in lesion profile. Recent research indicates that HSV-infected infants present microcephaly, heart ������������s ��d ������s��������� d�s��d��s (9) . I�d��d, ��s����� ��s ��d�����d ���� ~30% �� ������� d���v����s ��� ������������ ���������-������d (10) . T�� ���� �������s� �� ������������ ���������-��d���d ����� ��j��� �s ����� ����d-����� ������� ������������ ��d���d �� ����������g �������g���s�-stimulated inflammatory factors. This allows microorganisms to enter the fetal brain, causing injury and fever (11, 12 ����x��/�s������ �� ����� �����, ��d �������� ���s� ����d���� ��s ���� ����d �� ������s� 9-���d (13). I� �dd�����, s��d��s ��v� d����s�����d ���� 24-32 w��ks �� g�s�������� �g� w�s ��� ��s� v��������� �����d ��� ����� w���� ������. T��s �����d�-velopment stage is roughly equivalent to 2-5 day old neonatal ���s, w���� ��v� ���� ����d �� �� s�s�������� �� ��������� ��d hypoxia-induced inflammation (14, 15) . Therefore, it is entirely ��ss���� ���� ��� ������������ �������d ����s ��� ��v� �����d� d�v�����d ����� ��j��� ������ d���v���. A���� ���� ��s ������������� ��������, EPO ��s� ��s � neuro-protective role. Preliminary findings have indicated that �� ��� �� ��v��v�d �� ����� ����k���-����������d �����g���� regulation, although the mechanism is unclear (16, 17) . rhEPO �d����s������� �� �� ������������ ����� ����x��/�s������ ��� ��d�� w�s d������d �� ��� ���s, ��d������g ���� ��EPO �������d ��� ����d-����� ������� ��d ��������d ��� ����� ����� �� ��� ����d �����s���. H�w�v��, ���s ���������� s��d� ��v�s��g���d ������� ����x��/�s������ (18) ��d ������d����d ������� s��d��s s�gg�s���g ���� ��EPO ����d ��� ������ ��� blood-brain barrier (19) . Studies have indicated that brain NSE, neuron specific enolase; MBP, myelin basic protein; S100B, S100 protein B; Hb, hemoglobin; Ret, reticulocyte; Hct, hematocrit. 
